Natera to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum

PR Newswire

SAN CARLOS, Calif., Nov. 12, 2020

SAN CARLOS, Calif. , Nov. 12, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020 , at 1:30 p.m. PT ( 4:30 p.m. ET ).

Mike Brophy , Chief Financial Officer, will discuss Natera's latest developments and business activities.

Access to the live webcast and subsequent archived presentation will be available at investor.natera.com.

About Natera
Natera is a pioneer and global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California . It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com . Follow Natera on LinkedIn .

Contacts
Investor Relations: Mike Brophy , CFO, Natera, Inc., 510-826-2350
Media: Paul Greenland , VP of Corporate Marketing, Natera, Inc., pr@natera.com

SOURCE Natera, Inc.